Table 1.
LAGB | LRYGB | SADS | p value | |
---|---|---|---|---|
N | 24 | 14 | 15 | |
Male/female | 6/18 | 5/9 | 7/8 | .38 |
Agea | 71.9 ± 2 | 73.1 ± 2.5 | 73.6 ± 2.9 | .08 |
Weighta | 265.5 ± 35 | 253.2 ± 50.2 | 273.8 ± 36.3 | .46 |
BMIa | 44.3 ± 5.9 | 40.8 ± 5.2 | 44.2 ± 5.4 | .17 |
Comorbidity | ||||
Sleep apnea | 10/24 (42 %) | 10/14 (71 %) | 11/15 (73 %) | .08 |
Diabetes | 12/24 (50 %) | 6/14 (42 %) | 7/15 (47 %) | .97 |
GERD | 6/24 (25 %) | 6/14 (43 %) | 8/15 (53 %) | .19 |
Hypertension | 19/24 (79 %) | 12/14 (86 %) | 11/15 (73 %) | .71 |
LAGB laparoscopic gastric banding, LRYGB laparoscopic Roux-en-Y gastric bypass, SADS single anastomosis duodenal switch, GERD gastroesophageal reflux disease
aValues are expressed as mean ± standard deviation